Ready to Participate?
Already a member?
Have a question?
Healthcare Professionals
Join the MD Analytics Panel: Perspectives in Health to be invited to participate in paid health-related market research studies, such as online surveys, virtual interviews, and in-person focus groups.
Frequently Asked Questions about MD Analytics
MD Analytics provides market research services for the healthcare and pharmaceutical industry. We are committed to following the highest standards and care within our industry, abiding by the codes of conduct of the Canadian Research Insights Council, ESOMAR, and the Insights Association.
Why should I join the panel?
Participating in our market research studies provides opportunities for healthcare professionals to voice their opinions and inform key decisions impacting health policy and patient care. Participants also benefit from learning opportunities obtained through participating in market research and from incentives earned in exchange for their time and expert contribution.
What happens after I join?
Upon signing up to join the panel, you will be sent invitations via email to participate in online surveys, telephone interviews and/or focus groups that are relevant to your health profession and area of specialty. The study invitation will always indicate the type of study, topic, length of time required to complete the study and the incentive amount.
You decide whether a study interests you and participate as you wish. Upon completing a study, you will be paid the incentive specified.
How will my privacy be protected?
MD Analytics is committed to protecting the privacy of its research participants. When participating in our market research studies, all your responses remain anonymous and there is never any follow-up or attempt made to sell you anything.
MD Analytics is an Accredited Agency of the Canadian Research Insights Council and a member in good standing of the Insights Association. As such we are committed to going above and beyond these associations’ code of conduct, adhering to an audit every two years, to ensure we meet the highest standards.
Ready to join?
What will the content of the survey be used for and for whom?
The research sponsor and purpose will vary depending on the study. To not bias the research, we are unable to reveal their identity. However, most of our clients are multi-national pharmaceutical companies specializing in developing products and treatments for the therapeutic area of the study topic.
Are my responses anonymous?
Absolutely, your responses are anonymous. As a third-party market research firm, we never share your personal identifiable information with the research sponsor. Your responses will never be tied back to you as an individual. We always present the research findings as an aggregate between what you and your colleagues have collectively answered.
Will my name, title, or contact information be shared with research sponsors or publications?
No, we will never share that information to our clients nor any publications. If we need data from any of our physician panelists for a publication, we will state it explicitly in the first page of the survey and will ask for your consent to proceed.
How do I know if I qualify to participate?
Every online survey starts with a short eligibility section followed by the main survey. Each survey has different screening requirements, so we cannot guarantee eligibility every time. Every eligibility section will typically take from 15 seconds up to 2 minutes of your time.
What do you do with the data collected in the eligibility section?
We discard the data from the eligibility section, if you do not qualify to answer the main study questions. The data from the eligibility section is used for profiling and it is not useful for the study if it is not coupled with answers for the main survey.
How do I verify if the research is legitimate?
You can search the validity of our studies on the CRIC research verification service.
Latest Survey Results
How Do Oncologists Really View Sales Reps and MSLs?
Oncologists in the U.S. and Canada value different qualities in sales reps and MSLs. Our latest findings highlight where credibility, expertise, and engagement stand out and which companies earn the strongest recognition.
Leaders in Oncology
In oncology, the pace is fast and the competition fierce. Leaders stand out not only for groundbreaking therapies but also for building trust, brand recognition, and robust patient support programs.
MD Analytics surveyed U.S. and Canadian oncologists to learn which companies are in the lead and why. The findings reveal that perceived leadership goes beyond science alone; it’s about a commitment to patient care that resonates with both clinicians and patients.
View our latest infographic and blog to see how top companies are positioning themselves to maintain momentum and secure their place at the front of the field.
Use of Real-World Evidence in Oncology
Real-world evidence (RWE) is no longer a secondary data source, it’s becoming a core input in oncology treatment decisions. In a new survey of Canadian and U.S. oncologists, MD Analytics explores how RWE is being used in clinical practice, the scenarios where it’s most valuable, and what challenges still exist in applying it effectively.
Our latest infographic reveals where oncologists see the greatest benefit from RWE, how it supports complex decision-making, and what pharmaceutical companies can do to improve access, data quality, and clinical relevance.